PharmaLogic

PharmaLogic Development is a specialized product development consultancy founded in 2005 and based in Cleveland, USA. The company provides end-to-end strategic and operational support for the development of pharmaceuticals, biologics, and medical devices, with deep domain expertise in ophthalmology (notably glaucoma) and dermatology. Led by President Dr. Gary Novack, the firm operates as a service provider, helping clients navigate complex development pathways to achieve regulatory approval and commercialization efficiently. Its business model is built on consulting and development services rather than owning its own therapeutic pipeline.

Integrated service methodology and intellectual capital for medical product development, specializing in the interplay of pharmaceutics, safety assessment, and clinical planning for local therapies.

Competes within a fragmented market for development consulting services. Faces competition from large, full-service Contract Research Organizations (CROs), other specialized boutique consultancies in ophthalmology/dermatology, and independent consultants. Differentiation is based on deep therapeutic expertise, a track record of success, and a strategic, hands-on approach.